News
Learn more about whether UiPath Inc. or Pegasystems Inc. is a better investment based on AAII's A+ Investor grades, which ...
Learn more about whether The Descartes Systems Group Inc. or UiPath Inc. is a better investment based on AAII's A+ Investor ...
Cathie Wood’s ARK ETFs have made a series of trades on Wednesday, April 16th, 2025, with a notable increase in Robinhood Markets Inc (NASDAQ: HOOD) shares and a substantial sell-off of UiPath Inc ...
UiPath's recent Peak acquisition is likely to drive renewed growth opportunity. Read why we are reiterating our Buy rating ...
Morgan Stanley analyst Sanjit Singh maintained a Hold rating on UiPath (PATH – Research Report) today and set a price target of $12.00.Stay ...
Visa also continually rolls out new products that deliver benefits to customers, vendors, and merchants. Earlier in April, ...
Additionally, ARKX ETF increased its holdings in Iridium Communications Inc (NASDAQ: IRDM) by purchasing 10,389 shares worth $252,141. Iridium operates a satellite constellation providing voice and ...
(Nasdaq:CFLT), the data streaming pioneer, today announced the promotion of Ryan Mac Ban to Chief Revenue Officer (CRO). In this expanded role, Ryan will lead the global field strategy, bringing ...
UiPath (PATH) closed the most recent trading day at $10.71, moving -1.47% from the previous trading session. The stock's performance was behind the S&P 500's daily gain of 0.79%. Elsewhere, the Dow ...
General Motors Co. GM has decided to pause the production of its electric commercial vans at its Ontario plant due to ...
Cathie Wood's Ark Invest sold shares in UiPath, Prime Medicine, and Repare Therapeutics, with notable gains and losses.
Despite a 20% stock decline, we maintain a bullish view on UiPath due to its strategic pivot to Agentic AI and strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results